Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Nephros (NEPH) Other Operating Expenses (2016 - 2025)

Nephros has reported Other Operating Expenses over the past 14 years, most recently at $32000.0 for Q4 2025.

  • Quarterly results put Other Operating Expenses at $32000.0 for Q4 2025, down 5.88% from a year ago — trailing twelve months through Dec 2025 was $140000.0 (up 4.48% YoY), and the annual figure for FY2025 was $140000.0, up 3.7%.
  • Other Operating Expenses for Q4 2025 was $32000.0 at Nephros, down from $34000.0 in the prior quarter.
  • Over the last five years, Other Operating Expenses for NEPH hit a ceiling of $54000.0 in Q3 2023 and a floor of $32000.0 in Q1 2024.
  • Median Other Operating Expenses over the past 5 years was $42500.0 (2021), compared with a mean of $42550.0.
  • Biggest five-year swings in Other Operating Expenses: surged 1150.0% in 2021 and later crashed 39.62% in 2024.
  • Nephros' Other Operating Expenses stood at $47000.0 in 2021, then grew by 12.77% to $53000.0 in 2022, then fell by 3.77% to $51000.0 in 2023, then tumbled by 33.33% to $34000.0 in 2024, then decreased by 5.88% to $32000.0 in 2025.
  • The last three reported values for Other Operating Expenses were $32000.0 (Q4 2025), $34000.0 (Q3 2025), and $35000.0 (Q2 2025) per Business Quant data.